These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 29179888

  • 1. Secondary Prevention of CVD in LMIC: Care for the Growing Affected Population.
    Moran AE, Narula J.
    Glob Heart; 2017 Dec; 12(4):271-272. PubMed ID: 29179888
    [No Abstract] [Full Text] [Related]

  • 2. Global burden of CVD: focus on secondary prevention of cardiovascular disease.
    Bansilal S, Castellano JM, Fuster V.
    Int J Cardiol; 2015 Dec; 201 Suppl 1():S1-7. PubMed ID: 26747389
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. World Heart Federation Cholesterol Roadmap.
    Murphy A, Faria-Neto JR, Al-Rasadi K, Blom D, Catapano A, Cuevas A, Lopez-Jimenez F, Perel P, Santos R, Sniderman A, Sy R, Watts GF, Zhao D, Yusuf S, Wood D.
    Glob Heart; 2017 Sep; 12(3):179-197.e5. PubMed ID: 28765036
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.
    Cao Y, Lu L, Liang J, Liu M, Li X, Sun R, Zheng Y, Zhang P.
    Cell Biochem Biophys; 2015 May; 72(1):77-81. PubMed ID: 25427890
    [Abstract] [Full Text] [Related]

  • 7. Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.
    Packard KA, Hilleman DE.
    Cardiovasc Ther; 2016 Dec; 34(6):415-422. PubMed ID: 27473898
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease.
    van Kruijsdijk RC, van der Graaf Y, Algra A, de Borst GJ, Cramer MJ, Siersema PD, Peeters PH, Visseren FL, SMART study group.
    J Am Coll Cardiol; 2016 Dec 13; 68(23):2588-2589. PubMed ID: 27931618
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primary Prevention in LMIC: From Population-Based Surveys to Risk Factor Interventions.
    Moran AE, Narula J.
    Glob Heart; 2017 Sep 13; 12(3):177-178. PubMed ID: 29092759
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries.
    Dehghan M, Mente A, Teo KK, Gao P, Sleight P, Dagenais G, Avezum A, Probstfield JL, Dans T, Yusuf S, Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET)/Telmisartan Randomized Assessment Study in ACEI Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Trial Investigators.
    Circulation; 2012 Dec 04; 126(23):2705-12. PubMed ID: 23212996
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A glow in the secondary prevention of cardiovascular disease].
    Pedro-Botet J, Climent E.
    Clin Investig Arterioscler; 2017 Dec 04; 29(1):20-21. PubMed ID: 28173922
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Review of community-based interventions for prevention of cardiovascular diseases in low- and middle-income countries.
    van de Vijver S, Oti S, Addo J, de Graft-Aikins A, Agyemang C.
    Ethn Health; 2012 Dec 04; 17(6):651-76. PubMed ID: 23297746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.